biotx.ai
is building a data science team. We are seeking problem solvers that are energetic, efficient and fast learners to join our core technology team. The job is on a full-time basis at our office in Potsdam, Germany, but remote candidates will be considered. We put strong emphasis on culture and prioritize the creation of a fun and productive working environment that hosts the most experienced, well connected and smartest people in the industry. We are a group of genuinely decent people that never lay blame, love to solve difficult problems, innovate and challenge the status quo.
You will play a key role in an exciting early-stage AI business that is creating the next generation genetic association analysis platform, in conjunction with experienced leaders and institutions in the field. We are investing heavily into integrating classical analysis strategies, secure data management and data science to identify exploitable, actionable genetic variants to generate strong, robust candidates for downstream diagnostics and drug development. Your motivation will be to not only conquer a technically challenging environment, but to have a noticeable impact on healthcare and society as a whole. You will gain invaluable experience from collaborating with the founders and the core team of data scientists, engineers, and bioinformaticians. You will be developing a large-scale, robust and super-smart genetic analysis platform for drug development and getting involved with implementing the technical architecture, identifying useful technologies and developing advanced analysis tools. You will be expected to integrate tried and tested methods with creative new ideas. You will be a critical part to making the above a reality using the latest technology, languages, tools and frameworks.
biotx.ai
biotx.ai is the first company to go from biobank data all the way to a clinical trial phase 2b. We did so purely computationally, without a single wet lab experiment, for a fraction of the cost and 10 faster, via our synthetic clinical trial platform - all with <10 people, <2M USD seed funding. In addition to the drug in phase 2b, we have molecules in several disease areas in pre-clinical and phase 1.
We are now scaling up our operations. You will one of the first of a whole series of hires that will help us achieve success in this new stage of the company.
If this sounds like the "next big thing" and you want to discover more about the team then please send your CV through with subject title “biotx.ai
Data Science” to info@biotx.ai